BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.750
+0.148 (24.52%)
Nov 21, 2024, 1:29 PM EST - Market open

BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $21.75 million. The enterprise value is $20.60 million.

Market Cap 21.75M
Enterprise Value 20.60M

Important Dates

The next estimated earnings date is Thursday, December 12, 2024, after market close.

Earnings Date Dec 12, 2024
Ex-Dividend Date n/a

Share Statistics

BCTX has 35.84 million shares outstanding. The number of shares has increased by 5.35% in one year.

Current Share Class 35.84M
Shares Outstanding 35.84M
Shares Change (YoY) +5.35%
Shares Change (QoQ) +11.84%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 31.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.49

Current Ratio 0.49
Quick Ratio 0.21
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -126.11%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$299,467
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.29% in the last 52 weeks. The beta is 1.82, so BCTX's price volatility has been higher than the market average.

Beta (5Y) 1.82
52-Week Price Change -83.29%
50-Day Moving Average 0.78
200-Day Moving Average 1.54
Relative Strength Index (RSI) 52.17
Average Volume (20 Days) 621,108

Short Selling Information

The latest short interest is 745,065, so 2.08% of the outstanding shares have been sold short.

Short Interest 745,065
Short Previous Month 727,572
Short % of Shares Out 2.08%
Short % of Float 2.38%
Short Ratio (days to cover) 0.20

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -33.33M
Pretax Income -6.04M
Net Income -4.79M
EBITDA -33.25M
EBIT -33.33M
Earnings Per Share (EPS) -$0.29
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 862,089
Total Debt n/a
Net Cash 862,089
Net Cash Per Share $0.02
Equity (Book Value) -2.68M
Book Value Per Share -0.13
Working Capital -3.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.13 million and capital expenditures -$456,801, giving a free cash flow of -$24.58 million.

Operating Cash Flow -24.13M
Capital Expenditures -456,801
Free Cash Flow -24.58M
FCF Per Share -$0.69
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.35%
Shareholder Yield -5.35%
Earnings Yield -22.03%
FCF Yield -113.02%

Analyst Forecast

The average price target for BCTX is $15.00, which is 1,900.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.00
Price Target Difference 1,900.00%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 2, 2020. It was a reverse split with a ratio of 0.0033333:1.

Last Split Date Jan 2, 2020
Split Type Reverse
Split Ratio 0.0033333:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a